Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Behavioral Medicine
Published in: Annals of Behavioral Medicine 3/2012

01-06-2012 | BRIEF REPORT

History of Major Depressive Disorder Prospectively Predicts Worse Quality of Life in Women with Breast Cancer

Authors: Heather S. L. Jim, Ph.D., Brent J. Small, Ph.D., Susan Minton, D.O., Michael Andrykowski, Ph.D., Paul B. Jacobsen, Ph.D.

Published in: Annals of Behavioral Medicine | Issue 3/2012

Login to get access

Abstract

Background

Data are scarce about whether past history of major depressive disorder in the absence of current depression places breast cancer patients at risk for worse quality of life.

Purpose

The current study prospectively examined quality of life during chemotherapy in breast cancer patients with a history of resolved major depressive disorder (n = 29) and no history of depression (n = 144).

Methods

Women with Stages 0–II breast cancer were assessed prior to and at the completion of chemotherapy. Major depressive disorder was assessed via structured interview and quality of life with the SF-36.

Results

Patients with past major depressive disorder displayed greater declines in physical functioning relative to patients with no history of depression (p ≤ 0.01).

Conclusions

Findings suggest that breast cancer patients with a history of resolved major depressive disorder are at increased risk for declines in physical functioning during chemotherapy relative to patients with no history of depression.
Literature
1.
Oleske DM, Cobleigh MA, Phillips M, Nachman KL. Determination of factors associated with hospitalization in breast cancer survivors. Oncol Nurs Forum. 2004; 31:1081–1088.PubMedCrossRef
2.
Bui QU, Ostir GV, Kuo YF, Freeman J, Goodwin JS. Relationship of depression to patient satisfaction: Findings from the barriers to breast cancer study. Breast Cancer Res Treat. 2005; 89: 23–28.PubMedCrossRef
3.
Grabsch B, Clarke DM, Love A, et al. Psychological morbidity and quality of life in women with advanced breast cancer: A cross-sectional survey. Palliat Support Care. 2006; 4: 47–56.PubMedCrossRef
4.
Frick E, Tyroller M, Panzer M. Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: A cross-sectional study in a community hospital outpatient centre. Eur J Cancer Care (Engl). 2007; 16: 130–136.CrossRef
5.
Goodwin JS, Zhang DD, Ostir GV. Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc. 2004; 52: 106–111.PubMedCrossRef
6.
Colleoni M, Mandala M, Peruzzotti G, et al. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet. 2000; 356: 1326–1327.PubMedCrossRef
7.
Watson M, Haviland JS, Greer S, Davidson J, Bliss JM. Influence of psychological response on survival in breast cancer: A population-based cohort study. Lancet. 1999; 354: 1331–1336.PubMedCrossRef
8.
Phillips KA, Osborne RH, Giles GG, et al. Psychosocial factors and survival of young women with breast cancer: A population-based prospective cohort study. J Clin Oncol. 2008; 26: 4666–4671.PubMedCrossRef
9.
Watson M, Homewood J, Haviland J, Bliss JM. Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort. Eur J Cancer. 2005; 41: 1710–1714.PubMedCrossRef
10.
11.
Andersen BL. Predicting sexual and psychologic morbidity and improving the quality of life for women with gynecologic cancer. Cancer. 1993; 71: 1678–1690.PubMedCrossRef
12.
Costanzo ES, Lutgendorf SK, Mattes ML, et al. Adjusting to life after treatment: Distress and quality of life following treatment for breast cancer. Br J Cancer. 2007; 97: 1625–1631.PubMedCrossRef
13.
Kenne Sarenmalm E, Ohlen J, Oden A, Gaston-Johansson F. Experience and predictors of symptoms, distress and health-related quality of life over time in postmenopausal women with recurrent breast cancer. Psychooncology. 2008; 17: 497–505.
14.
Okamura M, Yamawaki S, Akechi T, Taniguchi K, Uchitomi Y. Psychiatric disorders following first breast cancer recurrence: Prevalence, associated factors and relationship to quality of life. Jpn J Clin Oncol. 2005; 35: 302–309.PubMedCrossRef
15.
Okano Y, Okamura H, Watanabe T, et al. Mental adjustment to first recurrence and correlated factors in patients with breast cancer. Breast Cancer Res Treat. 2001; 67: 255–262.PubMedCrossRef
16.
Jacobsen PB, Donovan KA, Small BJ, et al. Fatigue after treatment for early stage breast cancer: A controlled comparison. Cancer. 2007 110: 1851–1859.PubMedCrossRef
17.
Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996; 34: 73–84.PubMedCrossRef
18.
First MB, Gibbon M, Spitzer RL, Williams JB. User's Guide for the Structured Clinical Interview for the DSM-IV Axis I Disorders - Research Version. New York: Biometrics Research Department, New York State Psychiatric Institute, 1996.
19.
Radloff LS: The CES-D Scale. A self report depression scale for research in the general population. Appl Psychol Meas. 1977; 1: 119–135.CrossRef
20.
Beeber L, Shea J, McCorkle R. The Center for Epidemiological Studies Depression Scale as a measure of depressive symptoms in newly diagnosed patients. J Psychosoc Oncol. 1998; 16: 1–20.CrossRef
21.
Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: Evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res. 1999; 46: 437–443.PubMedCrossRef
22.
Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute, 1993.
23.
Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston: The Health Institute, 1994.
24.
Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986; 51: 1173–1182.PubMedCrossRef
25.
26.
Sobel ME. Asymptotic confidence intervals for indirect effects in structural equation models. Sociol Methodol. 1982; 13: 290–312.CrossRef
27.
Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care. 1988; 26: 775–789.PubMedCrossRef
28.
Cho HJ, Lavretsky H, Olmstead R, et al. Sleep disturbance and depression recurrence in community-dwelling older adults: A prospective study. Am J Psychiatry. 2008; 165: 1543–1550.PubMedCrossRef
29.
Solomon DA, Keller MB, Leon AC, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry. 2000; 157: 229–233.PubMedCrossRef
30.
Cho HJ, Lavretsky H, Olmstead R, et al. Prior depression history and deterioration of physical health in community-dwelling older adults--a prospective cohort study. Am J Geriatr Psychiatry. 2010; 18: 442–451.PubMedCrossRef
31.
Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 1992; 149: 999–1010.PubMed
32.
Monroe SM, Harkness KL. Life stress, the "kindling" hypothesis, and the recurrence of depression: Considerations from a life stress perspective. Psychol Rev. 2005; 112: 417–445.PubMedCrossRef
33.
Navari RM, Brenner MC, Wilson MN. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy. Breast Cancer Res Treat. 2008; 112: 197–201.PubMedCrossRef
34.
Morrow GR, Hickok JT, Roscoe JA, et al. Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol. 2003; 21: 4635–4641.PubMedCrossRef
35.
Roscoe JA, Morrow GR, Hickok JT, et al. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat. 2005; 89: 243–249.PubMedCrossRef
36.
Jacobsen PB, Jim HS. Psychosocial interventions for anxiety and depression in adult cancer patients: Achievements and challenges. CA Cancer J Clin. 2008; 58: 214–230.PubMedCrossRef
Metadata
Title
History of Major Depressive Disorder Prospectively Predicts Worse Quality of Life in Women with Breast Cancer
Authors
Heather S. L. Jim, Ph.D.
Brent J. Small, Ph.D.
Susan Minton, D.O.
Michael Andrykowski, Ph.D.
Paul B. Jacobsen, Ph.D.
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Annals of Behavioral Medicine / Issue 3/2012
Print ISSN: 0883-6612
Electronic ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-011-9333-6

Other articles of this Issue 3/2012

Annals of Behavioral Medicine 3/2012 Go to the issue

Original Article

AIDS-Related Stigma, HIV Testing, and Transmission Risk Among Patrons of Informal Drinking Places in Cape Town, South Africa

Original Article

Distinguishing Between-Person and Within-Person Relationships in Longitudinal Health Research: Arthritis and Quality of Life

Original Article

Acute Exercise Improves Physical Sexual Arousal in Women Taking Antidepressants

Original Article

The Effect of Patient–Provider Communication on Medication Adherence in Hypertensive Black Patients: Does Race Concordance Matter?

Brief Report

Transitions to Regular Smoking and Nicotine Dependence in the Adolescent National Comorbidity Survey (NCS-A)

Original Article

I (should) Need a Cigarette: Adolescent Social Anxiety and Cigarette Smoking